PH 2 ADI-PEG 20 Acute Myeloid Leukemia

Clinical trial NCT01910012 · COMPLETED

Trial details

NCT number: NCT01910012
Sponsor: Polaris Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2015-01-06
Primary completion: 2016-09-12
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.